{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:23:35Z","timestamp":1738733015800,"version":"3.37.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jiac.2024.02.004","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T03:08:03Z","timestamp":1707534483000},"page":"922-927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2265-6724","authenticated-orcid":false,"given":"Toshitaka","family":"Yukishima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4079-5509","authenticated-orcid":false,"given":"Kazuki","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Taki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5849-008X","authenticated-orcid":false,"given":"Shogo","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soma","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osanori","family":"Nagura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Katahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-0834","authenticated-orcid":false,"given":"Keita","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.02.004_bib1","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.7326\/M21-1757","article-title":"Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study","volume":"174","author":"Deepak","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2024.02.004_bib2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jiac.2024.02.004_bib3","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/annrheumdis-2021-220656","article-title":"High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases","volume":"80","author":"Ruddy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jiac.2024.02.004_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","article-title":"Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"80","author":"Strangfeld","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jiac.2024.02.004_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jamaoncol.2022.5357","article-title":"Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19","volume":"9","author":"Bakouny","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jiac.2024.02.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145145","article-title":"Serum CCL17 level becomes a predictive marker to distinguish between mild\/moderate and severe\/critical disease in patients with COVID-19","volume":"766","author":"Sugiyama","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.jiac.2024.02.004_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13808","article-title":"Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirement","volume":"52","author":"Suzuki","year":"2022","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.jiac.2024.02.004_bib8","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1164\/rccm.202002-0445OC","article-title":"COVID-19 with different severities: a multicenter study of clinical features","volume":"201","author":"Feng","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2024.02.004_bib9","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.immuni.2022.09.006","article-title":"SARS-CoV-2 in immunocompromised individuals","volume":"55","author":"DeWolf","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jiac.2024.02.004_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0041-1725183","article-title":"COVID-19 in an asymptomatic renal transplant recipient employed in the health care setting: a case report","volume":"31","author":"Adnani","year":"2022","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jiac.2024.02.004_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3201\/eid2803.211747","article-title":"Relationship of SARS-CoV-2 antigen and reverse transcription PCR positivity for viral cultures","volume":"28","author":"Currie","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2024.02.004_bib12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMcp2117115","article-title":"Rapid diagnostic testing for SARS-CoV-2","volume":"386","author":"Drain","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2024.02.004_bib13","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.02.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100902","article-title":"A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States","volume":"36","author":"Alfego","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jiac.2024.02.004_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(21)00479-5","article-title":"Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study","volume":"22","author":"Saur\u00e9","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2024.02.004_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/rheumatology\/keac089","article-title":"Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions","volume":"61","author":"Krasselt","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jiac.2024.02.004_bib17","first-page":"15","article-title":"Clinical efficacy of the neutralizing antibody therapy sotrovimab in patients with SARS-CoV-2 omicron BA.1 and BA.2 Subvariant Infections","author":"Miyashita","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jiac.2024.02.004_bib18","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jama.2022.2832","article-title":"Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial","volume":"327","author":"Gupta","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2024.02.004_bib19","unstructured":"Fact sheet for healthcare providers: Emergency use authorization for sotrovimab, https:\/\/www.fda.gov\/media\/149534\/download#:~:text=The%20Secretary\/20of\/20Health\/20and,CoV\/2D2\/20viral\/20testing\/2C\/20and."},{"key":"10.1016\/j.jiac.2024.02.004_bib20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/art.41596","article-title":"American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 3","volume":"73","author":"Mikuls","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jiac.2024.02.004_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14074","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients","volume":"45","author":"Sueki","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.jiac.2024.02.004_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.alit.2021.12.002","article-title":"Drug allergy and non-HIV immune reconstitution inflammatory syndrome","volume":"71","author":"Sueki","year":"2022","journal-title":"Allergol Int"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T16:32:24Z","timestamp":1738686744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1341321X24000345"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.02.004","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}